PKPhilip J. Kranzusch

Philip J. Kranzusch

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Recognitions

Top Cited Young Scholar (2026)
Top Cited Scholar (2025,2026)

Philip J. Kranzusch has a total of 223 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Phage proteases activate CBASS antiphage immunity

    by Samuel J. Hobbs, Philip J. Kranzusch

    Cyclic oligonucleotide–based antiphage signaling systems (CBASS) are bacterial immune pathways evolutionarily related to cGAS-STING (cyclic GMP-AMP synthase–stimulator of interferon genes) in humans. In CBASS, cGAS/DncV-like nucleotidyltransferase (CD-NTase) enzymes sense phage infection and synthesize nucleotide signals to initiate antiviral defense. Here, we reveal phage prohead protease activity as a widespread mechanism of CD-NTase activation. We reconstitute CBASS recognition of phage T4 in vitro and identify proteolytic cleavage of a CD-NTase activation loop as a trigger of immune signal synthesis. Phage prohead proteases directly activate CBASS in vivo, explaining how immunity is initiated late during infection. Structure-based phylogenetic analyses identify activation loops in clade A, D, and G CD-NTases and define residues controlling recognition of distinct phage families. Our results establish CBASS recognition of phage protease activity as a widespread antiviral defense mechanism.

  • Open Access

    Structure and operating principles of a monkeypox virus replisome

    by Zishuo Yu, Pradeep Sathyanarayana, Joel M. J. Tan, Side Hu, Xiaoyi Fan, Angela Gao, Philip J. Kranzusch, Joseph J. Loparo, Jonathan Abraham

    Poxviruses are double-stranded DNA viruses with large genomes. Among them, monkeypox virus (MPXV) has been responsible for two recent public health emergencies as declared by the World Health Organization 1 . The MPXV polymerase comprises three subunits—a catalytic subunit (F8) and a heterodimeric processivity factor (A22 and E4). The viral polymerase must coordinate activities with the hexameric helicase–primase (E5) to initiate replication of the viral genome 2 . Although structures of MPXV E5 (refs. 3,4 ) and the polymerase 5–7 in isolation are available, how they assemble into a functional replisome remains unclear. In isolation, E5 is in an autoinhibited conformation and has very weak helicase activity 3,4 , and the mechanism for helicase activation is unclear. Here we used cryo-electron microscopy to determine the structures of DNA-bound MPXV replisomes comprising the polymerase holoenzyme (F8, A22 and E4) and the E5 helicase hexamer. We show that, during replisome assembly, E5 undergoes large-scale conformational changes that allow two of its primase domains to interact with the polymerase F8 thumb and A22 subunit. Biochemical assays and single-molecule experiments reveal that this E5 conformational change is coupled to helicase activation and enhances primase activity. Taken together, these findings identify fundamental mechanisms governing coordinated helicase and polymerase activities during DNA replication for an important class of viral pathogens.

  • Open Access

    Bacterial diadenylate cyclase domains synthesize diverse nucleotide signals in anti-phage defense

    by Adelyn E. Ragucci, Danielle J. Haley, Philip J. Kranzusch

    Bacterial diadenylate cyclase (DAC) enzymes synthesize the nucleotide signal 3′3′ cyclic di-AMP (3′3′-c-di-AMP) to control osmoregulation, cell-wall homeostasis, and DNA-damage responses. Here we discover specialized roles for DAC enzymes in bacterial immunity and define a Panoptes-like system we name Panoptoo as a DAC-containing anti-phage defense that guards against viral immune evasion. The Panoptoo protein PanS is a minimal DAC that constitutively synthesizes 3′3′ cyclic UMP-AMP (3′3′-cUA) or 3′3′-c-di-AMP to negatively regulate a partnering PanE S2TMβ membrane-targeting effector. We show that Panoptoo decoy signaling acts as a counter-defense to detect phage immune evasion proteins that inhibit nucleotide immune signals. A 1.5 Å crystal structure of PanS in complex with 3′3′-cUA explains how a symmetry break in the canonical DAC active site enables synthesis of asymmetric signaling molecules. Together, our results uncover a role for DAC domains in bacterial anti-phage defense and expand our understanding of nucleotide signaling in antiviral immunity.

  • Functional diversity of phage sponge proteins that sequester host immune signals

    by Romi Hadary, Renee B. Chang, Nathalie Béchon, Nitzan Tal, Ilya Osterman, Erez Yirmiya, Jeremy Garb, Miguel López Rivera, Gil Amitai, Philip J. Kranzusch, et al.

    Many bacterial immune systems use signalling molecules that activate the immune response following phage infection. Phages counteract bacterial immune signalling using sponge proteins that bind and sequester the immune signals, but their functional diversity and versatility have not been fully explored. Here we study Acb2, Tad1 and Tad2, three families of sponge proteins known to inhibit CBASS (cyclic oligonucleotide-based anti-phage signalling system) and Thoeris signalling. Eighty-four proteins representing the phylogenetic diversity of these sponge families were tested for their ability to inhibit immunity by sequestering seven distinct signals from CBASS, Thoeris and Pycsar defence systems. While Acb2 proteins were so far reported to inhibit only CBASS, we found Acb2 homologues that bind 3'cADPR and inhibit Thoeris defence. We also discovered sponge proteins that inhibit Pycsar and type IV Thoeris by binding cUMP and N7-cADPR, respectively. Using crystal structures, structural modelling and biochemical analyses, we explain the molecular basis for signal-binding specificities in these sponge families.


  • Open Access

    Phage RyR-domain proteins degrade ADPR-based immune signals and fuel NAD + synthesis

    by Miguel López Rivera, Renee B. Chang, Colin M. Lewis, Romi Hadary, Julia M. Kovalski, Krista G. Freeman, Zhen-Yu J. Sun, Rotem Sorek, Graham F. Hatfull, Philip J. Kranzusch

    Bacterial, plant, and animal cells synthesize nucleotide immune signals as a conserved strategy to defend against viral infection 1–4 . In bacteria, Thoeris anti-phage defense systems convert nicotinamide adenine dinucleotide (NAD + ) into the cyclic ADP-ribose signals 2′cADPR and 3′cADPR to activate downstream effectors and restrict viral replication 5–8 . Phage proteins can bind and sequester Thoeris signals 6,9–13 , but no mechanisms are known to degrade the exceptionally stable 2′cADPR and 3′cADPR molecules and terminate immune activation. Here we use a forward biochemical screen to discover the mycobacteriophage protein RyDEP as the founding member of an enzyme family that cleaves 2′cADPR and 3′cADPR to inactivate Thoeris defense. We show that RyDEP is a glycosidase that cleaves the ribose-ribose linkage in 2′ and 3′ cADPR immune signals to both inactivate host defense and enable direct restoration of NAD + . A crystal structure of the RyDEP–3′cADPR complex in the post-cleavage state explains the molecular basis of immune signal degradation and reveals surprising homology with the Repeat12 domain of animal ryanodine receptors (RyRs) that control calcium flux and muscle contraction 14,15 . We demonstrate that diverse phage RyDEP proteins tune RyR-domain activity to either degrade or sequester immune signals. Our results define RyR-domain proteins as regulators of nucleotide immune signaling and explain how viruses subvert host antiviral defense.


  • Nuclease–NTPase antiphage defence systems use conserved molecular features to control bacterial immunity

    by Adelyn E. Ragucci, Sadie P. Antine, Ethan M. Leviss, Sarah E. Mooney, Jasmine M. Garcia, Lena Shyrokova, Vasili Hauryliuk, Amy S. Y. Lee, Philip J. Kranzusch

    Bacteria encode diverse defence systems, including restriction-modification and CRISPR-Cas, that cleave nucleic acid to protect against phage infection. Bioinformatic analyses demonstrate that many recently identified antiphage defence operons comprise a nuclease and NTPase protein, suggesting that additional nucleic acid-targeting systems remain to be understood. Here we develop large-scale comparative cell biology and biochemical approaches to analyse 16 nuclease-NTPase systems and define molecular features that control antiphage defence. Purification, biochemical characterization and in vitro reconstitution of nucleic acid degradation demonstrates that protein-protein complex formation is a shared feature of multigene nuclease-NTPase systems. We show that PaAbpAB, BtHachiman and EcPD-T4-8 system nucleases use highly degenerate recognition site preferences to enable broad nucleic acid degradation, and the Azaca system exhibits specific phage targeting through the recognition of modified phage genomic DNA. Our results uncover principles of antiphage defence system function and highlight the mechanistic diversity of nuclease-NTPase systems in bacterial immunity.


  • Open Access

    Structural basis of QueC-family protein function in qatABCD anti-phage defense

    by Angela Gao, Douglas R. Wassarman, Philip J. Kranzusch

    QueC proteins are nucleoside biosynthesis enzymes required for production of the 7-deazaguanine derivative queuosine. Recently, QueC-family proteins were also shown to catalyze a deazaguanylation protein-nucleobase conjugation reaction in type IV CBASS bacterial anti-phage defense. Here we determine the structural basis of QueC-family protein function in a distinct bacterial immunity system named qatABCD. We demonstrate that the Pseudomonas aeruginosa QueC-family protein QatC forms a specific complex with the immunity protein QatB and that this complex is minimally required for qatABCD defense. Crystal structures of the QatBC complex enable direct comparison of qatABCD and type IV CBASS defense and support a shared role for QueC-family proteins in targeting protein substrates for N-terminal modification. We show that the QatB unstructured N-terminus and N-terminal glycine motif are essential for qatABCD defense in vivo, suggesting a modification occurs analogous to CBASS deazaguanylation. These findings highlight broad roles of QueC proteins beyond nucleoside biosynthesis and suggest that adaptation of QueC-like proteins for specialized biochemical functions is a common strategy in bacterial anti-phage immunity.


  • Open Access

    Phage protease enzymes activate CBASS antiphage immunity

    by Samuel J. Hobbs, Philip J. Kranzusch

    Cyclic oligonucleotide-based antiphage signaling systems (CBASS) are immunity pathways in bacteria that use a cGAS/DncV-like nucleotidyltransferase (CD-NTase) enzyme to sense phage infection and initiate antiviral defense. Bacteria encode thousands of diverse CBASS operons, demonstrating a critical role for CD-NTase activation in controlling the prokaryotic response to viral infection. Here we discover proteolytic cleavage by phage prohead proteases as a mechanism of CD-NTase activation and demonstrate that diverse CBASS operons function as molecular sensors of protease activity. We reconstitute CBASS recognition of phage T4 infection in vitro and identify proteolytic cleavage of a surface exposed CD-NTase activation loop as a trigger of enzyme catalysis and nucleotide immune signal synthesis. Phage prohead proteases are sufficient to activate CBASS in vivo and explain how immune signaling is initiated during late stages of viral infection. Combining biochemical and structure-based phylogenetic analyses, we map activation loops in Clade A, D, and G CD-NTase enzymes and define critical residues that control CBASS recognition of distinct phage families. Our results define CBASS recognition of phage protease activity as a widespread mechanism of antiviral defense.


  • Top Cited Papers

    Structural modeling reveals phage proteins that manipulate bacterial immune signaling

    by Nitzan Tal, Romi Hadary, Renee B. Chang, Ilya Osterman, Roy Jacobson, Erez Yirmiya, Nathalie Bechon, Dina Hochhauser, Miguel López Rivera, Barak Madhala, et al.

    Immune systems in animals, plants, and bacteria often rely on intracellular nucleotide signaling, which viruses can block by sequestering or degrading these signals. We identified structural and biophysical traits shared by diverse viral antidefense proteins and used these traits to develop a computational pipeline that predicts phage proteins whose role is to manipulate bacterial immune signaling. Experimental validation revealed three previously uncharacterized protein families—Sequestin, Lockin, and Acb5—that inhibit the Thoeris system and the cyclic oligonucleotide–based antiphage signaling system (CBASS). Sequestin and Lockin act as nucleotide “sponges,” binding 1″–3′ glycocyclic adenosine diphosphate–ribose (3′cADPR) and histidine conjugated to ADPR (His- ADPR), whereas Acb5 cleaves cyclic guanosine monophosphate–adenosine monosphosphate (3′3′-cGAMP) and related molecules. Structural and mutational analyses explain their binding and catalytic mechanisms. Thousands of homologs occur in phage genomes, highlighting the abundance and diversity of viral strategies to subvert nucleotide-based immunity.